• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Cesca Therapeutics Inc

+ Add to Watchlist


0.867 EUR 0.003 0.35%

As of 04:35:44 ET on 11/28/2014.

Snapshot for Cesca Therapeutics Inc (THRA)

Open: 0.874 Day's Range: 0.847 - 0.877 Volume: 0
Previous Close: 0.864 52wk Range: 0.499 - 2.259 1-Yr Rtn: +73.75%

Stock Chart for THRA

No chart data available.
  • THRA:GR 0.877
  • 1D
  • 1M
  • 1Y
Interactive THRA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THRA

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2015) -0.3600
Est. PEG Ratio -
Market Cap (M EUR) 34.93
Shares Outstanding (M) 40.29
30 Day Average Volume 235
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THRA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THRA

Cesca Therapeutics, Inc. operates as a supplier of products targeting the worldwide adult stem cell market. The Company offers automated and semi-automated devices and single-use processing disposables that enable the collection, processing and cryopreservation of stem cells and other cellular tissues from cord blood and bone marrow used in regenerative medicine.

Robin C StraceyInterim CEOKenneth L Harris "Ken"President
Dan T BesseyChief Financial OfficerMitchel Sivilotti "Mitch"Chief Biologist
More Company Profile & Key Executives for THRA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil